Loading...
•
Sep 30, 2021
PROCEPT BioRobotics Q3 2021 Earnings Report
Reported third quarter results with revenue increase driven by system sales to new and existing hospital customers.
Key Takeaways
PROCEPT BioRobotics reported strong third-quarter results, with total revenue reaching $8.7 million, a significant increase from $2.1 million in the prior year period. The company's U.S. system revenue was $5.0 million, compared to $0.6 million in the prior year period. The company issued 2021 total revenue guidance range of $33.0 to $33.3 million.
Total revenue for Q3 2021 was $8.7 million, compared to $2.1 million in the prior year period.
U.S. system revenue for Q3 2021 was $5.0 million, compared to $0.6 million in the prior year period.
U.S. handpiece revenue for Q3 2021 was $2.2 million, compared to $0.5 million in the prior year period.
International revenue for Q3 2021 was $1.3 million, compared to $1.0 million in the prior year period.
PROCEPT BioRobotics
PROCEPT BioRobotics
PROCEPT BioRobotics Revenue by Segment
PROCEPT BioRobotics Revenue by Geographic Location
Revenue by Segment
U.S. System Sales & Rentals Revenue
CapyFin.comU.S. Handpieces & Consumables Revenue
CapyFin.comInternational System Sales & Rentals Revenue
CapyFin.comInternational Handpieces & Consumables Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company expects full year 2021 revenue to be in the range of $33.0 to $33.3 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income